DHX9-IN-6
DHX9-IN-6 (Compound 620) is an ATP-dependent inhibitor of RNA helicase A (DHX9) with potential for cancer research[1].
Product Specifications
CAS Number
2973401-56-6
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dhx9-in-6.html
Purity
98.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C2=C(OCC3=CC(F)=CN=C3)C=CC=N2)=CS1)NC4=CC(Cl)=CC(NS(=O)(C)=O)=C4
Molecular Formula
C23H18ClFN4O4S2
Molecular Weight
532.99
References & Citations
[1]DANIELS Matthew H., et al. Preparation of imidazopyridines, thienopyrimidines, pyrrolopyrimidines and related heterocycles as inhibitors of RNA helicase DHX9 useful in treatment of cancers. World Intellectual Property Organization, WO2023154519 A1 2023-08-17
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471826-100 1x 100 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (N/A), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-B446685-50MG 50 mg
2,2-Bis-(4-hydroxyphenyl)hexafluoropropane Monosulfate Sodium Salt
Sign In for Pricing
View Details ![TPMT Mouse Monoclonal Antibody [Clone ID: AT2E7]](https://cdn.genprice.uk/products/937/68dd189b061270361e8fc554/imageurl/am09399pu-s.webp)
